QbD is an industry initiative supported by regulators. However, it is also a systematic method of process development which delivers consistency, robustness and increased process knowledge. This course introduces QbD across all areas of pharmaceutical development including synthesis, formulation and analysis, and suggests practical recommendations for the implementation of QbD. Participants will learn how to identify and prioritise process parameters, determine and manage risk, and implement control strategies. COURSE OUTLINE
WHO SHOULD ATTEND?
The use of experimental design (DoE) in QbD, the identification of potential mixing and scale-up problems, and the safe scale up of processes to pilot and manufacturing plants will also be discussed. For the benefit of process scientists, engineers, formulators, analytical chemists and manufacturing personnel, this course includes highly interactive, hands-on workshops, based on several case studies.
Chemists, engineers, analysts and formulators in pharmaceutical development. Anyone involved with the development of new or existing drug products; changes or improvements to existing or generic drugs are subject to QbD principals.
Dr Paul Murray
BOOK WITH CONFIDENCE!
14 - 18 June 1.30-5.30pm (UK) Each Day
£1,595.00 + VAT Online
FULL REFUNDS GIVEN ON FACE TO FACE MEETINGS IF WE ARE NOT ABLE TO RUN THE COURSE OR YOU ARE NOT ABLE TO TRAVEL DEPENDING ON THE CURRENT PANDEMIC SITUATION.
16 - 18 November
TO BOOK please either visit our website www.scientificupdate.com or email firstname.lastname@example.org
Made with FlippingBook Online document